Industry Trend Analysis - Almirall On Course To Adopt Leading Position In EU Dermatology Market - SEPT 2017
Western Europe July 2017 / Spain / Industry
Skilarence will capitalise on an existing but underutilised psoriasis product market; unlike the existing dimethyl fumarate product, Fumaderm, it will be available as a licensed medicine across the...
Industry Trend Analysis - Psoriasis Research Collaboration Will Bring Substantial Rewards For Almirall And Nuevolution - FEB 2017
Western Europe January 2017 / Spain / Industry
This agreement will see Almirall further develop its Dermatology franchise. The firm is placing increasing importance on this niche area, an effort that is reflected in the franchise's growing...
Industry Trend Analysis - Population Ageing To Influence Pharmaceutical Regulations - AUG 2016
Western Europe July 2016 / Spain / Industry
The ageing population of Spain, and the wider Europe region, will create significant revenue earning opportunities for drugmakers as the demand for medicines for the treatment of chronic diseases...
Industry Trend Analysis - Spanish Generic Industry Poised To Benefit From Proposed EC SPC Waiver - MAR 2016
Western Europe February 2016 / Spain / Industry
Measures to improve access to generics in Spain, a country that lags behind others in the EU for generic penetration, will lead to an increase in purchasing power at individual and state-level. Spanish generic manufacturers will be able to take advantage of the EC's proposed supplementary protection certificate waiver, the effect of which will be to increase R&D expertise in Spain...
READ FULL ARTICLE
Industry Trend Analysis - Roche Investment Highlights Minoryx' Rare Disease Potential - JAN 2016
Western Europe November 2015 / Spain / Industry
Minoryx's MIN-102 targets an area of currently unmet medical need in the rare disease X-ALD. Investment from Roche Venture Fund will allow accelerated development and signals a high underlying...
Industry Trend Analysis - Spanish Successes Will Validate Bluefish's Business Strategy - OCT 2015
Western Europe September 2015 / Spain / Industry
These latest tender successes in Spain demonstrate how Bluefish Pharmaceuticals is developing its business by focusing on the more underdeveloped markets. Whilst the company's revenues are relative...
Industry Trend Analysis - Market Access Barriers To Continue To Challenge Drugmakers - JUNE 2015
Western Europe May 2015 / Spain / Industry
Spain's non-transparent and unpredictable government medicine pricing system and the implementation of numerous emergency measures to contain pharmaceutical spending is highly disruptive to drugmak...
Industry Trend Analysis - Prescription Drugmakers To Continue To Face Challenges - MAY 2015
Western Europe April 2015 / Spain / Industry
Despite calls made by pharmaceutical companies for the implementation of a system that adequately rewards innovation and supports investment in future medicines, ongoing debt issues will result in...
Industry Trend Analysis - Public Pharmaceutical Expenditure To Decline - FEB 2015
Western Europe January 2015 / Spain / Industry
The weak Spanish economy and the government's multi-faceted strategy to contain expenditure on medicines by targeting patients, companies and the overall healthcare sector present ongoing challenge...
Industry Trend Analysis - Generic Medicines Consumption To Rise - DEC 2014
Western Europe October 2014 / Spain / Industry
The Spanish government's pro-generic stance will result in the growth of generic medicine sales and losses for the patented-medicines sector. However, we highlight that the loss of market value in...